RAMM Pharma Corp Valuation
Based on Macroaxis valuation methodology, the entity cannot be evaluated at this time. RAMM Pharma Corp recent Real Value cannot be determined due to lack of data. The prevailing price of RAMM Pharma Corp is $0.0. Our model determines the value of RAMM Pharma Corp from evaluating the entity fundamentals such as shares outstanding of 122.4 M, and Return On Asset of -0.0789 as well as inspecting its technical indicators and probability of bankruptcy.
RAMM Pharma Total Value Analysis
RAMM Pharma Corp is at this time expected to have takeover price of 1.85 M with market capitalization of 15.16 M, debt of 8.69 K, and cash on hands of 12.79 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the RAMM Pharma fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.85 M | 15.16 M | 8.69 K | 12.79 M |
RAMM Pharma Investor Information
About 35.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.18. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. RAMM Pharma Corp recorded a loss per share of 0.05. The entity had not issued any dividends in recent years. Based on the key measurements obtained from RAMM Pharma's financial statements, RAMM Pharma Corp is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April.RAMM Pharma Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. RAMM Pharma has an asset utilization ratio of 6.89 percent. This implies that the Company is making $0.0689 for each dollar of assets. An increasing asset utilization means that RAMM Pharma Corp is more efficient with each dollar of assets it utilizes for everyday operations.RAMM Pharma Ownership Allocation
RAMM Pharma owns a total of 122.4 Million outstanding shares. RAMM Pharma Corp has substantial amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company maintains, if the real value of the entity is less than the current market value, you may not be able to make money on it.RAMM Pharma Profitability Analysis
The company reported the revenue of 4.12 M. Net Loss for the year was (7.11 M) with loss before overhead, payroll, taxes, and interest of (37.32 K).Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates RAMM Pharma's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in RAMM Pharma and how it compares across the competition.
RAMM Pharma Growth Indicators
Investing in growth stocks can be very risky. If the company such as RAMM Pharma does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 123.4 M | |
| Retained Earnings | -22.4 M | |
| Shares Float | 89.2 M |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Consideration for investing in RAMM Pink Sheet
If you are still planning to invest in RAMM Pharma Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the RAMM Pharma's history and understand the potential risks before investing.
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Commodity Directory Find actively traded commodities issued by global exchanges |